JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1992; 20:161-168
© 1992 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perrone-Filardi, P
Right arrow Articles by Bonow, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perrone-Filardi, P
Right arrow Articles by Bonow, R.

Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischemic left ventricular dysfunction

P Perrone-Filardi, SL Bacharach, V Dilsizian, S Maurea, JA Marin-Neto, JA Arrighi, JA Frank, and RO Bonow

National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.

Reduced end-diastolic wall thickness with absent systolic wall thickening has been reported to represent nonviable myocardium in patients with chronic coronary artery disease. To assess whether reduced regional end-diastolic wall thickness and absent wall thickening accurately identify nonviable myocardium, 25 patients with ischemic left ventricular dysfunction (ejection fraction at rest 27 +/- 10%) underwent positron emission tomography with oxygen-15-labeled water and 18fluorodeoxyglucose to assess metabolic activity and spin-echo gated nuclear magnetic resonance imaging to measure regional end-diastolic wall thickness and wall thickening. The presence of metabolic activity was defined as 18fluorodeoxyglucose uptake (corrected for partial volume) greater than 50% of that in normal regions. Of 355 myocardial regions evaluated, 266 were hypokinetic or normokinetic at rest and 89 were akinetic (that is, absent wall thickening). 18Fluorodeoxyglucose uptake was observed in 97% of the hypokinetic and normokinetic regions and in 74% of the akinetic regions. End-diastolic wall thickness was greater in akinetic regions with than in those without 18fluorodeoxyglucose uptake (11 +/- 4 vs. 7 +/- 3 mm, p less than 0.01). The highest values for sensitivity and specificity of end-diastolic wall thickness in predicting the absence of metabolic activity in akinetic regions were 74% and 79%, respectively, and corresponded to an end-diastolic threshold of 8 mm. However, the positive predictive accuracy was only 55% and did not improve for other end-diastolic wall thickness values. In all myocardial regions, there was only a weak correlation between 18fluorodeoxyglucose activity and either end-diastolic wall thickness (r = 0.17) or wall thickening (r = 0.32). Thus, metabolic activity is present in many regions with reduced end-diastolic wall thickness and absent wall thickening. These data indicate that assessment of regional anatomy and function may be inaccurate in distinguishing asynergic but viable myocardium from nonviable myocardium.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
Y. Zhang, A. K.Y. Chan, C.-M. Yu, G. W.K. Yip, J. W.H. Fung, W. W.M. Lam, N. M.C. So, M. Wang, E. B. Wu, J. T. Wong, et al.
Strain Rate Imaging Differentiates Transmural From Non-Transmural Myocardial Infarction: A Validation Study Using Delayed-Enhancement Magnetic Resonance Imaging
J. Am. Coll. Cardiol., September 6, 2005; 46(5): 864 - 871.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. N. Mazzadi, M. F. Janier, B. Brossier, X. Andre-Fouet, E. McFadden, D. Revel, and P. Croisille
Dobutamine-tagged MRI for inotropic reserve assessment in severe CAD: relationship with PET findings
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1946 - H1953.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H. Mahrholdt, A. Wagner, R.M. Judd, and U. Sechtem
Assessment of myocardial viability by cardiovascular magnetic resonance imaging
Eur. Heart J., April 2, 2002; 23(8): 602 - 619.
[Full Text] [PDF]


Home page
Eur Heart JHome page
G LaCanna, S.H Rahimtoola, O Visioli, R Giubbini, O Alfieri, M Zognio, E Milan, C Ceconi, M Gargano, R LoRusso, et al.
Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium
Eur. Heart J., August 2, 2000; 21(16): 1358 - 1367.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Salati, M. Lemma, D. G. Di Mattia, P. Danna, A. Cialfi, A. Salvaggio, and C. Santoli
Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: Functional Observations
Ann. Thorac. Surg., December 1, 1997; 64(6): 1728 - 1734.
[Abstract] [Full Text]


Home page
CirculationHome page
P. Perrone-Filardi, L. Pace, M. Prastaro, F. Squame, S. Betocchi, A. Soricelli, F. Piscione, C. Indolfi, T. Crisci, M. Salvatore, et al.
Assessment of Myocardial Viability in Patients With Chronic Coronary Artery Disease: Rest–4-Hour–24-Hour 201Tl Tomography Versus Dobutamine Echocardiography
Circulation, December 1, 1996; 94(11): 2712 - 2719.
[Abstract] [Full Text]


Home page
CirculationHome page
C. R. deFilippi, D. L. Willett, W. N. Irani, E. J. Eichhorn, C. E. Velasco, and P. A. Grayburn
Comparison of Myocardial Contrast Echocardiography and Low-Dose Dobutamine Stress Echocardiography in Predicting Recovery of Left Ventricular Function After Coronary Revascularization in Chronic Ischemic Heart Disease
Circulation, November 15, 1995; 92(10): 2863 - 2868.
[Abstract] [Full Text]


Home page
CirculationHome page
E. E. van der Wall, H. W. Vliegen, A. de Roos, and A. V.G. Bruschke
Magnetic Resonance Imaging in Coronary Artery Disease
Circulation, November 1, 1995; 92(9): 2723 - 2739.
[Abstract] [Full Text]


Home page
CirculationHome page
P. Perrone-Filardi, L. Pace, M. Prastaro, F. Piscione, S. Betocchi, F. Squame, P. Vezzuto, A. Soricelli, C. Indolfi, M. Salvatore, et al.
Dobutamine Echocardiography Predicts Improvement of Hypoperfused Dysfunctional Myocardium After Revascularization in Patients With Coronary Artery Disease
Circulation, May 15, 1995; 91(10): 2556 - 2565.
[Abstract] [Full Text]


Home page
CirculationHome page
F. M. Baer, E. Voth, C. A. Schneider, P. Theissen, H. Schicha, and U. Sechtem
Comparison of Low-Dose Dobutamine–Gradient-Echo Magnetic Resonance Imaging and Positron Emission Tomography With [18F]Fluorodeoxyglucose in Patients With Chronic Coronary Artery Disease : A Functional and Morphological Approach to the Detection of Residual Myocardial Viability
Circulation, February 15, 1995; 91(4): 1006 - 1015.
[Abstract] [Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1992 by the American College of Cardiology Foundation.